PRESS RELEASE published on 10/27/2025 at 22:15, 9 months 23 days ago Onco-Innovations Announces Closing of Private Placement Onco-Innovations Limited closes non-brokered private placement, issuing 1,428,570 units for gross proceeds of $2,000,000. Funds to be used for corporate purposes and cancer research. Statutory hold period applies to securities issued Private Placement Securities Cancer Research Statutory Hold Period Onco-Innovations Limited
BRIEF published on 10/15/2025 at 02:05, 10 months 5 days ago Onco-Innovations Announces $2 Million Private Placement Private Placement Warrants Regulatory Approval Onco-Innovations Christopher Gulka
BRIEF published on 10/15/2025 at 02:05, 10 months 5 days ago Onco-Innovations annonce un placement privé de 2 millions de dollars Placement Privé Mandats Approbation Réglementaire Onco-Innovations Christophe Gulka
PRESS RELEASE published on 10/15/2025 at 02:00, 10 months 5 days ago Onco-Innovations Announces Private Placement Onco-Innovations Limited announces non-brokered private placement of up to $2,000,000 and appointment of Mr. Christopher Gulka to the Board of Directors Board Of Directors Private Placement Appointment Onco-Innovations Limited Christopher Gulka
BRIEF published on 09/29/2025 at 06:05, 10 months 21 days ago Onco-Innovations et Nucro-Technics lancent le programme préclinique PNKP Etudes Précliniques Onco-Innovations Technologie PNKP Nucro-Techniques Développement Analytique
BRIEF published on 09/29/2025 at 06:05, 10 months 21 days ago Onco-Innovations and Nucro-Technics Initiate Preclinical PNKP Program Preclinical Studies Onco-Innovations PNKP Technology Nucro-Technics Analytical Development
PRESS RELEASE published on 09/29/2025 at 06:00, 10 months 21 days ago Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology Onco-Innovations collaborates with Nucro-Technics for preclinical drug development services focusing on PNKP Technology. Nucro-Technics initiates lab work under IND enabling program with advanced analytical methods based on LC-MS Preclinical Onco-Innovations PNKP Technology Nucro-Technics Analytical Methods
BRIEF published on 09/22/2025 at 23:05, 10 months 27 days ago Onco-Innovations Appoints Dr. Michael Lock to Advisory Board Cancer Research Onco-Innovations PNKP Inhibitor Clinical Advisory Board Dr. Michael Lock
BRIEF published on 09/22/2025 at 23:05, 10 months 27 days ago Onco-Innovations nomme le Dr Michael Lock au conseil consultatif Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Dr Michael Lock Conseil Consultatif Clinique
PRESS RELEASE published on 09/22/2025 at 23:00, 10 months 27 days ago Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board Onco-Innovations appoints Dr. Michael Lock, an expert in oncology and clinical trial design, to its Advisory Board. The company also grants RSUs to key personnel Cancer Research RSUs Onco-Innovations Dr. Michael Lock Clinical Trial Design
Published on 08/20/2026 at 09:10, 30 minutes ago HM Exploration Announces DTC Eligibility of Its Common Shares in the United States
Published on 08/20/2026 at 02:22, 7 hours 18 minutes ago Infrastructure Sterilisation Drilling Begins at Tunkillia
Published on 08/20/2026 at 00:40, 9 hours ago Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
Published on 08/19/2026 at 22:00, 11 hours 40 minutes ago Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/20/2026 at 09:00, 39 minutes ago Schaeffler and CATL deepen collaboration on Battery Management Systems and Integrated PowerBox Solutions
Published on 08/20/2026 at 09:00, 39 minutes ago Original-Research: SMAG Mobile Antenna Masts AG (von NuWays AG): BUY
Published on 08/20/2026 at 09:00, 39 minutes ago Original-Research: Flughafen Wien AG (von NuWays AG): BUY
Published on 08/20/2026 at 09:00, 39 minutes ago Original-Research: Steyr Motors AG (von NuWays AG): BUY
Published on 08/18/2026 at 18:00, 1 day 15 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 15 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 22 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 22 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 13 hours ago Aéroports de Paris S.A - July 2026 traffic figures